ACHE and Alzheimer disease: Thus, these findings imply that a high AChE activity is physiologically counterbalanced by high in vivo nicotinic binding sites in the brain of AD patients (as depicted schematically in Figure 5D), possibly due to low availability and/or short duration of action of ACh.